In this Review, the authors provide an introduction to machine learning and discuss the use of this approach in rheumatic autoimmune inflammatory diseases, including the classification of patients based on medical records or molecular characteristics, identification of novel biomarkers or drug repurposing candidates and prediction of disease progression or onset.
- Kathryn M. Kingsmore
- Christopher E. Puglisi
- Peter E. Lipsky